Immuneering (IMRX) Q1 2025 Earnings

20MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.58
-0.53
-0.47
-0.42

Details

Expected EPS
-0.416
Actual EPS
-0.58
Surprise EPS
-0.16
Surprise Percent
+39.42%

Description

Immuneering (IMRX) has reported earnings of -0.58 per share for Q1 2025.

0 Comments

Share your thoughts